Articles tagged as 'VigiBase'

12 results

Building better data bridges between pharmacovigilance databases in the Americas and VigiBase
Since 2021 PAHO has assisted 12 countries in importing more than 270,000 historic and new cases to the global database.

Keeping vaccines safe – New podcast on COVID-19 vaccine surveillance
UMC experts discuss how real-time vaccine surveillance works during a pandemic and the role of VigiBase in helping to ensure public safety.

Digging deeper into Montelukast and nightmares
There is much to be gained from using VigiBase to further explore known adverse reactions to drugs, as some may be having more of an impact on patients than first thought.

Pharmacovigilance in Brazil
Despite the difficulties in monitoring drug safety in a country with more than 200 million inhabitants, Brazil's pharmacovigilance system is undergoing profound change.

Text is key for eliminating duplicate reports
Duplicate case reports are an obstacle to effective pharmacovigilance but identifying them is a difficult and laborious task.

Weeding out duplicates to better detect side-effects – New podcast episode
Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them.

Uncovering pregnancy cases in VigiBase
To tackle the lack of medicine and vaccine safety data for pregnant people, UMC has developed an algorithm to more easily identify pregnancy-related reports in VigiBase.

WHO and UMC enhance data sharing clarity with new VigiBase access conditions
WHO and UMC introduce new VigiBase access conditions, enhancing data sharing clarity and stakeholder confidence in global pharmacovigilance.

Pregnancy-related pharmacovigilance – New podcast episode
Discover how researchers are addressing crucial challenges in pregnancy-related pharmacovigilance to better protect both mothers and their unborn children.

New film goes behind the scenes of UMC’s pandemic operations
A new short film captures UMC's work to support the pharmacovigilance community as it prepares to take on COVID-19. Filmmaker Matthew Barwick explains the thinking behind it.